Skip to main content

Table 9 Oxidative status: MDA, PCc, 8-OHdG

From: Effect of 8-week n-3 fatty-acid supplementation on oxidative stress and inflammation in middle- and long-distance running athletes: a pilot study

  

T0

SD

T1

SD

p value

%

 

MDA URINE (μmol/ml)

ATHL

0.030

0.017

0.019

0.011

0.02

36.67

T1vsT0

SED

0.016

0.02

0.017

0.011

0.45

5.88

T1vsT0

     

0.10

46.67

T0

     

0.70

10.53

T1

MDA BASAL PLASMA (μmol/ml)

ATHL

0.026

0.015

0.002

0.002

1*10−6

90.59

T1vsT0

SED

0.003

0.002

0.001

0.001

0.01

58.82

T1vsT0

     

6*10−4

86.67

T0

     

0.30

41.67

T1

MDA STIMULATED PLASMA (μmol/ml)

ATHL

0.053

0.017

0.016

0.003

7.0*10−8

69.19

T1vsT0

SED

0.018

0.002

0.015

0.002

1*10−3

18.03

T1vsT0

     

2.7*10−5

65.41

T0

     

0.30

7.98

T1

PCc (nmol/mg)

ATHL

3.83

2.85

3.73

2.32

0.92

2.71

T1vsT0

SED

3.50

2.12

5.31

1.61

0.1

34.01

T1vsT0

     

0.76

8.61

T0

     

0.09

29.75

T1

8-OHdG (ng/ml)

ATHL

27.87

22.50

56.47

45.60

0.11

50.65

T1vsT0

SED

73.77

75.00

67.32

63.90

0.87

8.74

T1vsT0

     

0.2

62.36

T0

     

0.72

16.12

T1

  1. Data are expressed as mean values ± SD comparing two groups and two periods. Statistical analysis: repeated measures analysis of variance; level of significance: p < 0.05; % for the difference between mean values, T1vs T0 intra-group, Sedentary (SED) vs Athlete (ATHL) groups for T0 and T1